Party Drug Ketamine (Special K) Likely To Become Anti-Depression Medicine
The drug Ketamine, known in the party scene as "Special K," could have a future in depression treatment. Pharmaceutical companies are racing to create a patentable version of the drug and researchers are trying to learn more about the effects it has on the brain. Ketamine works by blocking the signalling molecule NMDA, which is a component of the glutamate pathway. This pathway is involved with memory and cognition, psychiatrist James Murrough at the Mount Sinai Hospital in New York City, explained to Nature magazine.
- Dr. James Murrough, Assistant Professor, Psychiatry, Neuroscience, Icahn School of Medicine at Mount Sinai
Wildfire Smoke May Be More Harmful Than Other Air Pollution, Two Mount Sinai Studies Find
Sep 17, 2026 View All Press Releases
Researchers Discover Rare Cortical Neurons That Can Help Put the Brain to Sleep
Sep 11, 2026 View All Press Releases
